Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6

Date first appeared online	28/04/2022
DOI	10.1186/s12933-022-01489-6
Authors	Bain S.
Journal Name	Cardiovascular Diabetology
Volume	21

Documents

• 59680.pdf , Book, © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License